Mass spectrometry-based measurement of phosphorylation changes in response to drug treatment

被引：0
|
作者：
Dunkley, T. [1 ]
Jones, S. [1 ]
Nickson, J. [1 ]
Hickinson, M. [1 ]
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
来源：
MOLECULAR & CELLULAR PROTEOMICS | 2006年 / 5卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
163
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] Mass spectrometry-based clinical proteomics
    Pusch, W
    Flocco, MT
    Leung, SM
    Thiele, H
    Kostrzewa, M
    PHARMACOGENOMICS, 2003, 4 (04) : 463 - 476
  • [42] Mass spectrometry-based retina proteomics
    Prokai, Laszlo
    Zaman, Khadiza
    Prokai-Tatrai, Katalin
    MASS SPECTROMETRY REVIEWS, 2023, 42 (03) : 1032 - 1062
  • [43] Immunoproteomics - Mass spectrometry-based methods to study the targets of the immune response
    Purcell, AW
    Gorman, JJ
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (03) : 193 - 208
  • [44] Origins of mass spectrometry-based proteomics
    Matthias Mann
    Nature Reviews Molecular Cell Biology, 2016, 17 : 678 - 678
  • [45] Challenges in mass spectrometry-based proteomics
    Reinders, J
    Lewandrowski, U
    Moebius, J
    Wagner, Y
    Sickmann, A
    PROTEOMICS, 2004, 4 (12) : 3686 - 3703
  • [46] Impact of Mass Spectrometry-Based Technologies and Strategies on Chemoproteomics as a Tool for Drug Discovery
    McClure, Ryan A.
    Williams, Jon D.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (08): : 785 - 791
  • [47] A Mass Spectrometry-based Method to Detect Antiviral Drug Resistance in Human Cytomegalovirus
    Posthuma, Clara
    Van der Beek, Martha
    Van der Blij, Caroline
    Spaan, Willy
    Kroes, Louis
    Snijder, Eric
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A51 - A51
  • [48] Drug profiling and biomarker discovery using mass spectrometry-based proteomics technologies
    Jenne, A.
    Tebbe, A.
    Schaab, C.
    Godl, K.
    Kaminski, M.
    Mueller, S.
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S29 - S29
  • [49] Mass Spectrometry-Based Protein Biomarker Discovery and Measurement: Sensitivity is the Greatest Hurdle
    Lance A. Liotta
    Emanuel F. Petricoin
    Clinical Proteomics, 2010, 6 (1-2) : 4 - 5
  • [50] Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment
    Haga, Yoshimi
    Minegishi, Yuriko
    Ueda, Koji
    CANCER SCIENCE, 2023, 114 (05) : 1783 - 1791
12345